Skip to main content
Fig. 3 | Orphanet Journal of Rare Diseases

Fig. 3

From: Intravenous administration of a branched-chain amino-acid-free solution in children and adults with acute decompensation of maple syrup urine disease: a prospective multicentre observational study

Fig. 3

A Predicted and observed time to leucine normalisation, efficacy set (n = 85). Box plot of predicted versus observed time (in days) to leucine normalisation. Dotted lines indicate mean time to leucine normalisation. B Predicted and observed time to leucine normalisation by age categories (n = 18/67). Box plot of predicted versus observed time (in days) to leucine normalisation for episodes in children and in adults. Dotted lines indicate mean time to leucine normalisation

Back to article page

Orphanet Journal of Rare Diseases

ISSN: 1750-1172